1st Quarter - Report
INTRA-CELLULAR THERAPIES, INC. for INTRA-CELLULAR THERAPIES, INC.
Income
—
Expenses
$70,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
H.R. 1492 - EPIC Act: Provisions regarding harmonizing small and large molecule period in the Inflation Reduction Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREW SPERLING | — |
Taxation/Internal Revenue Code TAX
H.R. 1990 - American Innovation and R&D Competitiveness Act: Provisions regarding Section 174 research and development tax credit amortization.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREW SPERLING | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.